Drug related morbidity and mortality updating the cost of illness Adult couples chat room
In direct patient care, increased emphasis should be paid to appropriate targeting or case finding for high-risk patients.
This concept has been adopted by accreditation bodies such as the Joint Commission (Oakbrook Terrace, IL, USA), which maintains a list of high-alert medications.
Aim of the study The present study aimed to assess medications most commonly associated with TRPs within the outpatient setting.
Thus, the current study is an advanced step of our previous study, focusing on relating TRPs with specific medications/groups of medication in an effort to create a sort of focused TRP medication list.
Accepted for publication 26 September 2018 Published 16 November 2018 Volume 20 Pages 2273—2281 DOI https://doi.org/10.2147/TCRM.
S180747 Checked for plagiarism Yes Review by Single-blind Peer reviewers approved by Dr Amy Norman Peer reviewer comments 2 Editor who approved publication: Professor Garry Walsh School of Pharmacy and Pharmaceutical Science, University of Ulster, Coleraine, County Londonderry, UK Background: Treatment-related problems (TRPs) may pose risks for patients if unaddressed.
Search for drug related morbidity and mortality updating the cost of illness:
Patients selection During the study period (September 2102–December 2013), patients who attended cardiology, endocrine, and respiratory outpatient clinics and met the selection criteria were invited to take part in the study.